Megan Mescher serves as the Executive Vice President at Tox and Tonic, where she is at the forefront of transforming the cosmetic industry through innovative business models. With a rich background that began as a Bone Marrow Transplant and Oncology Nurse at Rush Presbyterian St....
Megan Mescher serves as the Executive Vice President at Tox and Tonic, where she is at the forefront of transforming the cosmetic industry through innovative business models. With a rich background that began as a Bone Marrow Transplant and Oncology Nurse at Rush Presbyterian St. Luke’s Hospital in Chicago, Meg has cultivated a unique blend of clinical expertise and business acumen. Her early career in nursing ignited her passion for healthcare technology, leading her to manage and sell surgical robots in the mid-90s, a pivotal experience that honed her skills in market access and strategic planning.
At Tox and Tonic, Meg is instrumental in driving key projects that empower Nurse and Mid-Level Injectors to establish their own businesses within a scalable and accessible framework. The company’s membership-based practice solution is designed to be “plug and play,” allowing partners to seamlessly integrate into the aesthetic market. Under her leadership, Tox and Tonic has successfully implemented a model grounded in three core principles: education, community, and support, ensuring that injectors not only thrive but also deliver exceptional patient care.
Meg's expertise in negotiation and her deep understanding of the aesthetics landscape enable her to forge strategic partnerships that enhance the company’s reach and impact. Her multifaceted skill set, which includes investments and working closely with surgeons, positions her as a pivotal figure in the ongoing evolution of cosmetic practices. As Tox and Tonic continues to disrupt traditional models, Megan Mescher remains committed to fostering innovation and accessibility in the beauty industry, making a lasting impact on both practitioners and clients alike.
